Anavex Life Sciences Ownership 2024 | Who Owns Anavex Life Sciences Now?
Institutional Ownership
32.46%
Insider Ownership
3.05%
Retail Ownership
64.49%
Institutional Holders
147.00
Anavex Life Sciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 7.75% | 0.00% | 6,391,472 | -254,066 | -3.82% | 26,972,011 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.52% | 0.00% | 4,548,219 | 133,537 | 3.02% | 19,193,484 | Jun 30, 2024 |
| STATE STREET CORP | 4.54% | 0.00% | 3,740,356 | -3,558,651 | -48.76% | 15,784,302,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.22% | 0.00% | 1,831,253 | 118,526 | 6.92% | 7,729,052 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.23% | 0.01% | 1,012,883 | 477,336 | 89.13% | 4,274,366 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.81% | 0.00% | 669,156 | -49,599 | -6.90% | 2,823,838,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.79% | 0.00% | 651,084 | 21,017 | 3.34% | 2,747,574 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.73% | 0.00% | 600,359 | -250,769 | -29.46% | 2,533,515 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 466,437 | 386,537 | 483.78% | 1,968,364 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.55% | 0.00% | 457,163 | -77,049 | -14.42% | 1,929,227 | Jun 30, 2024 |
| MORGAN STANLEY | 0.53% | 0.00% | 437,840 | 97,210 | 28.54% | 1,847,686 | Jun 30, 2024 |
| SCULPTOR CAPITAL LP | 0.45% | 0.03% | 371,400 | - | - | 1,567,308 | Jun 30, 2024 |
| SCULPTOR CAPITAL LP | 0.45% | 0.03% | 370,400 | - | - | 1,563,088 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.37% | 0.00% | 304,165 | 38,373 | 14.44% | 1,283,576 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.34% | 0.00% | 280,556 | 40,895 | 17.06% | 1,183,948 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.27% | 0.00% | 224,314 | -445,631 | -66.52% | 946,605 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.27% | 0.07% | 220,860 | 199,965 | 957.00% | 932,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.21% | 0.00% | 175,900 | -388,800 | -68.85% | 742,298 | Jun 30, 2024 |
| UBS GROUP AG | 0.17% | 0.00% | 142,639 | -272,844 | -65.67% | 601,936 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.15% | 0.00% | 120,880 | 40,480 | 50.35% | 510,114 | Jun 30, 2024 |
Anavex Life Sciences's largest institutional shareholder is BLACKROCK INC., holding 7.75% of the company's total share outstanding, currently valued at $26.97M. The top 10 institutional shareholders own together 24.70% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALLSQUARE WEALTH MANAGEMENT LLC | 0.06% | 0.13% | 51,966 | - | - | 219,297 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.27% | 0.07% | 220,860 | 199,965 | 957.00% | 932,000 | Jun 30, 2024 |
| SAXON INTERESTS, INC. | 0.03% | 0.05% | 26,699 | - | - | 112,670 | Jun 30, 2024 |
| HIKARI POWER LTD | 0.10% | 0.03% | 85,585 | - | - | 361,000 | Jun 30, 2024 |
| SCULPTOR CAPITAL LP | 0.45% | 0.03% | 371,400 | - | - | 1,567,308 | Jun 30, 2024 |
| SCULPTOR CAPITAL LP | 0.45% | 0.03% | 370,400 | - | - | 1,563,088 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.11% | 0.02% | 94,578 | 94,578 | 100.00% | 399,119 | Jun 30, 2024 |
| OPUS CAPITAL GROUP, LLC | 0.04% | 0.02% | 32,700 | 2,200 | 7.21% | 138,000 | Jun 30, 2024 |
| HAYEK KALLEN INVESTMENT MANAGEMENT | 0.01% | 0.02% | 11,863 | 540 | 4.77% | 50,000 | Jun 30, 2024 |
| FOSTER VICTOR WEALTH ADVISORS, LLC | 0.04% | 0.02% | 35,663 | - | - | 207,915 | Jun 30, 2024 |
| GENEOS WEALTH MANAGEMENT INC. | 0.11% | 0.02% | 89,725 | 15,325 | 20.60% | 378,640 | Jun 30, 2024 |
| HAMILTON POINT INVESTMENT ADVISORS, LLC | 0.02% | 0.02% | 20,300 | - | - | 85,666 | Jun 30, 2024 |
| BNC WEALTH MANAGEMENT, LLC | 0.01% | 0.02% | 10,250 | -6,850 | -40.06% | 43,255 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.04% | 0.01% | 29,294 | 29,294 | 100.00% | 124,000 | Jun 30, 2024 |
| INCEPTIONR LLC | 0.01% | 0.01% | 10,971 | 10,971 | 100.00% | 46,298 | Jun 30, 2024 |
| FIDUCIARY ALLIANCE LLC | 0.02% | 0.01% | 19,275 | 6,000 | 45.20% | 79,606 | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | 0.03% | 0.01% | 23,000 | - | - | 97,060 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.23% | 0.01% | 1,012,883 | 477,336 | 89.13% | 4,274,366 | Jun 30, 2024 |
| CARNEGIE CAPITAL ASSET MANAGEMENT, LLC | 0.09% | 0.01% | 73,333 | - | - | 309,465 | Jun 30, 2024 |
| PREMIER PATH WEALTH PARTNERS, LLC | 0.02% | 0.01% | 12,500 | - | - | 52,750 | Jun 30, 2024 |
The largest Anavex Life Sciences shareholder by % of total assets is ALLSQUARE WEALTH MANAGEMENT LLC. The company owns 51.97K shares of Anavex Life Sciences (AVXL), representing 0.13% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | 1.23% | 0.01% | 1,012,883 | 477,336 | 89.13% | 4,274,366 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 466,437 | 386,537 | 483.78% | 1,968,364 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.27% | 0.07% | 220,860 | 199,965 | 957.00% | 932,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.52% | 0.00% | 4,548,219 | 133,537 | 3.02% | 19,193,484 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.22% | 0.00% | 1,831,253 | 118,526 | 6.92% | 7,729,052 | Jun 30, 2024 |
| MORGAN STANLEY | 0.53% | 0.00% | 437,840 | 97,210 | 28.54% | 1,847,686 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.11% | 0.02% | 94,578 | 94,578 | 100.00% | 399,119 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.11% | 0.00% | 94,204 | 94,204 | 100.00% | 397,000 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.10% | 0.01% | 81,890 | 81,890 | 100.00% | 345,576 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.06% | 0.00% | 45,866 | 45,866 | 100.00% | 194,146 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.06% | 0.00% | 45,352 | 45,352 | 100.00% | 191,385 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.34% | 0.00% | 280,556 | 40,895 | 17.06% | 1,183,948 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.15% | 0.00% | 120,880 | 40,480 | 50.35% | 510,114 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.05% | 0.00% | 39,351 | 39,351 | 100.00% | 166,062 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 39,163 | 39,163 | 100.00% | 165,268 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.37% | 0.00% | 304,165 | 38,373 | 14.44% | 1,283,576 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 0.07% | 0.00% | 54,883 | 36,711 | 202.02% | 231,606 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.04% | 0.01% | 29,294 | 29,294 | 100.00% | 124,000 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.05% | 0.00% | 45,219 | 26,821 | 145.78% | 190,824 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.03% | 0.00% | 25,801 | 25,801 | 100.00% | 108,881 | Jun 30, 2024 |
As of Jun 30 2024, Anavex Life Sciences's largest institutional buyer is TWO SIGMA INVESTMENTS, LP. The company purchased 477.34K stocks of AVXL, valued at $4.27M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 4.54% | 0.00% | 3,740,356 | -3,558,651 | -48.76% | 15,784,302,000 | Jun 30, 2024 |
| NWAM LLC | - | - | - | -836,730 | -100.00% | - | Jun 30, 2024 |
| JUPITER ASSET MANAGEMENT LTD | - | - | - | -804,642 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.27% | 0.00% | 224,314 | -445,631 | -66.52% | 946,605 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.21% | 0.00% | 175,900 | -388,800 | -68.85% | 742,298 | Jun 30, 2024 |
| UBS GROUP AG | 0.17% | 0.00% | 142,639 | -272,844 | -65.67% | 601,936 | Jun 30, 2024 |
| BLACKROCK INC. | 7.75% | 0.00% | 6,391,472 | -254,066 | -3.82% | 26,972,011 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.73% | 0.00% | 600,359 | -250,769 | -29.46% | 2,533,515 | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -161,500 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -96,924 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -83,185 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.55% | 0.00% | 457,163 | -77,049 | -14.42% | 1,929,227 | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.01% | - | 5,275 | -75,777 | -93.49% | 22,261 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.03% | 0.00% | 22,077 | -65,854 | -74.89% | 93,165 | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | 0.01% | - | 6,600 | -64,487 | -90.72% | 27,852 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.05% | 0.01% | 41,280 | -61,758 | -59.94% | 174,202 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -60,813 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -59,776 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.03% | 0.00% | 24,349 | -58,731 | -70.69% | 102,753 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -58,008 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Anavex Life Sciences's biggest institutional seller is STATE STREET CORP. The company sold -3.56M shares of AVXL, valued at $15.78B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| Y-INTERCEPT (HONG KONG) LTD | 0.11% | 0.02% | 94,578 | 94,578 | 100.00% | 399,119 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.11% | 0.00% | 94,204 | 94,204 | 100.00% | 397,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.06% | 0.00% | 45,866 | 45,866 | 100.00% | 194,146 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.05% | 0.00% | 39,351 | 39,351 | 100.00% | 166,062 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 39,163 | 39,163 | 100.00% | 165,268 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.04% | 0.01% | 29,294 | 29,294 | 100.00% | 124,000 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.03% | 0.00% | 25,801 | 25,801 | 100.00% | 108,881 | Jun 30, 2024 |
| INCEPTIONR LLC | 0.01% | 0.01% | 10,971 | 10,971 | 100.00% | 46,298 | Jun 30, 2024 |
| MAN GROUP PLC | 0.01% | 0.00% | 10,685 | 10,685 | 100.00% | 45,091 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.00% | 0.01% | 4,001 | 4,001 | 100.00% | 16,884 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.00% | - | 2,152 | 2,152 | 100.00% | 9,081 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | 0.00% | - | 250 | 250 | 100.00% | 1,055 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 200 | 200 | 100.00% | 844 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | 0.00% | - | 60 | 60 | 100.00% | 253 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | - | 56 | 56 | 100.00% | 240 | Jun 30, 2024 |
Anavex Life Sciences's largest new institutional shareholder by number of shares is Y-INTERCEPT (HONG KONG) LTD, purchased 94.58K shares, valued at $399.12K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NWAM LLC | - | - | - | -836,730 | -100.00% | - | Jun 30, 2024 |
| JUPITER ASSET MANAGEMENT LTD | - | - | - | -804,642 | -100.00% | - | Jun 30, 2024 |
| SWISS NATIONAL BANK | - | - | - | -161,500 | -100.00% | - | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | - | - | - | -96,924 | -100.00% | - | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -83,185 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -60,813 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -59,776 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -58,008 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -40,612 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -35,624 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | - | - | - | -32,213 | -100.00% | - | Jun 30, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | - | - | - | -22,559 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -20,007 | -100.00% | - | Jun 30, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | - | - | - | -18,268 | -100.00% | - | Jun 30, 2024 |
| D.A. DAVIDSON & CO. | - | - | - | -13,770 | -100.00% | - | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | - | - | - | -12,200 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| MARINER, LLC | - | - | - | -10,919 | -100.00% | - | Jun 30, 2024 |
| STRATOS WEALTH PARTNERS, LTD. | - | - | - | -10,802 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -10,407 | -100.00% | - | Jun 30, 2024 |
| AMUNDI | - | - | - | -3,340 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,040 | -100.00% | - | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | - | - | - | -748 | -100.00% | - | Jun 30, 2024 |
| COSTON, MCISAAC & PARTNERS | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| BANGOR SAVINGS BANK | - | - | - | -150 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -115 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -14 | -100.00% | - | Jun 30, 2024 |
Anavex Life Sciences's largest sold out institutional shareholder by shares sold is NWAM LLC, sold -0.84M shares, valued at -, as of undefined.
Anavex Life Sciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.11% | 55,577 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.04% | 111,569 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 132,540 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,977 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.02% | 177,823 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.02% | 371 | - | - | Dec 31, 2023 |
| Federated Hermes MDT Series | 0.01% | 35,179 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 124,590 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 31,849 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.01% | 62,160 | 5,911 | 10.51% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,497,852 | -1,177,950 | -25.19% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,840 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 202,192 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 60,143 | 2,260 | 3.90% | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 397,014 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 28,899 | - | - | Aug 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 802,024 | 62,975 | 8.52% | Feb 29, 2024 |
| ProFunds | 0.00% | 34,574 | 20,960 | 153.96% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,976 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 43,464 | -690 | -1.56% | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 7,257 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 44,887 | -3,768 | -7.74% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 222,776 | 10,088 | 4.74% | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 31,116 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 278,635 | 8,138 | 3.01% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 11,574 | -951 | -7.59% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 433 | - | - | Apr 30, 2021 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 17,634 | 335 | 1.94% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 24,711 | -3,864 | -13.52% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 432,308 | 24,257 | 5.94% | Feb 29, 2024 |
| Global X Funds | 0.00% | 32,172 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,531 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 2,361 | - | - | Mar 28, 2024 |
| Dunham Funds | 0.00% | 31,892 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,126 | - | - | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 13,344 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 4,927 | 576 | 13.24% | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 52,819 | -2,001 | -3.65% | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 23,900 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 17,097 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 16,227 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 1,661 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 6,399 | - | - | Jan 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 2,000 | - | - | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 3,269,526 | -176,192 | -5.11% | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 3,868 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 203,775 | -12,584 | -5.82% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 331,991 | 44,575 | 15.51% | Feb 29, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 14,708 | - | - | Mar 28, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 641 | - | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 5,581,641 | 3,511,257 | 169.59% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 13,742 | - | - | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 10,126 | -244 | -2.35% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 781 | - | - | Feb 29, 2024 |
| Meeder Funds | 0.00% | 591 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 13,846 | -64 | -0.46% | Jan 31, 2024 |
| VALIC Co I | 0.00% | 27,740 | 266 | 0.97% | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 10,383 | - | - | Mar 28, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 19,861 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,500 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 11,323 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 318 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 6,886 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 16,723 | 2,283 | 15.81% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 28,143 | - | - | Jan 31, 2024 |
| PGIM ETF TRUST | 0.00% | 3,470 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 3,061 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 143,940 | 7,465 | 5.47% | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 10,637 | 1,901 | 21.76% | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,323 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 42 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 78,639 | 4,299 | 5.78% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 3,495 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 30,524 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 10,489 | 78 | 0.75% | Jan 31, 2024 |
| Pacer Funds Trust | 0.00% | 1,268 | -1,367 | -51.88% | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,611 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,179 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 535 | - | - | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 1,306 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 397 | - | - | Jan 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 1,980 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 15,309 | -7,983 | -34.27% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 28,109 | 969 | 3.57% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 4,374 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 35,745 | 4,221 | 13.39% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 2,199 | 755 | 52.29% | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 20,030 | -47,001 | -70.12% | Dec 31, 2023 |
| Series Portfolios Trust | 0.00% | 40 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 22,817 | -406 | -1.75% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 5,357 | - | - | Dec 31, 2023 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,273 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 13,547 | - | - | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 245 | 54 | 28.27% | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 41,157 | 8,020 | 24.20% | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 8,432 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 11,135 | -2,274 | -16.96% | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 9,069 | 2,117 | 30.45% | Jan 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 3,719 | - | - | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 6,740 | - | - | Feb 29, 2024 |
Anavex Life Sciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 55.58K shares, compromising 0.11% of its total assets.
Anavex Life Sciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 147 | -6.96% |
| 31 Mar, 24 | 158 | -5.39% |
| 31 Dec, 23 | 167 | 9.87% |
| 30 Sep, 23 | 152 | -0.65% |
| 30 Jun, 23 | 153 | 2.00% |
| 31 Mar, 23 | 150 | -0.66% |
| 31 Dec, 22 | 151 | -2.58% |
| 30 Sep, 22 | 155 | -1.27% |
| 30 Jun, 22 | 157 | 7.53% |
| 31 Mar, 22 | 146 | -6.41% |
| 31 Dec, 21 | 156 | 5.41% |
| 30 Sep, 21 | 148 | 7.25% |
| 30 Jun, 21 | 138 | 24.32% |
| 31 Mar, 21 | 111 | 18.09% |
| 31 Dec, 20 | 94 | 18.99% |
| 30 Sep, 20 | 79 | 5.33% |
| 30 Jun, 20 | 75 | 5.63% |
| 31 Mar, 20 | 71 | 9.23% |
| 31 Dec, 19 | 65 | 6.56% |
| 30 Sep, 19 | 61 | -1.61% |
| 30 Jun, 19 | 62 | 6.90% |
| 31 Mar, 19 | 58 | 11.54% |
| 31 Dec, 18 | 52 | 1.96% |
| 30 Sep, 18 | 51 | -12.07% |
| 30 Jun, 18 | 58 | - |
| 31 Mar, 18 | 58 | -7.94% |
| 31 Dec, 17 | 63 | -3.08% |
| 30 Sep, 17 | 65 | -4.41% |
| 30 Jun, 17 | 68 | 3.03% |
| 31 Mar, 17 | 66 | 1.54% |
| 31 Dec, 16 | 65 | 8.33% |
| 30 Sep, 16 | 60 | 20.00% |
| 30 Jun, 16 | 50 | 11.11% |
| 31 Mar, 16 | 45 | 32.35% |
| 31 Dec, 15 | 34 | - |
As of 30 Jun 24, 147 institutions are holding Anavex Life Sciences's shares, representing a decrease of -6.96% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 26,770,048 | -15.94% |
| 31 Mar, 24 | 31,845,742 | 23.59% |
| 31 Dec, 23 | 25,766,532 | 3.24% |
| 30 Sep, 23 | 24,959,010 | -0.86% |
| 30 Jun, 23 | 25,175,353 | -6.73% |
| 31 Mar, 23 | 26,990,575 | 0.34% |
| 31 Dec, 22 | 26,897,954 | 10.84% |
| 30 Sep, 22 | 24,268,235 | -2.12% |
| 30 Jun, 22 | 24,792,611 | -0.62% |
| 31 Mar, 22 | 24,947,521 | 13.35% |
| 31 Dec, 21 | 22,009,083 | 7.11% |
| 30 Sep, 21 | 20,548,480 | -4.63% |
| 30 Jun, 21 | 21,545,452 | 18.87% |
| 31 Mar, 21 | 18,125,597 | 30.28% |
| 31 Dec, 20 | 13,912,893 | 10.21% |
| 30 Sep, 20 | 12,624,130 | 7.11% |
| 30 Jun, 20 | 11,785,587 | 1.05% |
| 31 Mar, 20 | 11,663,361 | -16.02% |
| 31 Dec, 19 | 13,888,413 | 4.59% |
| 30 Sep, 19 | 13,278,778 | 13.05% |
| 30 Jun, 19 | 11,746,318 | 59.62% |
| 31 Mar, 19 | 7,358,717 | 9.89% |
| 31 Dec, 18 | 6,696,700 | -18.33% |
| 30 Sep, 18 | 8,199,587 | -9.51% |
| 30 Jun, 18 | 9,061,385 | -11.61% |
| 31 Mar, 18 | 10,252,047 | 1.39% |
| 31 Dec, 17 | 10,111,662 | 1.02% |
| 30 Sep, 17 | 10,009,424 | -2.69% |
| 30 Jun, 17 | 10,286,149 | 9.83% |
| 31 Mar, 17 | 9,365,767 | 24.85% |
| 31 Dec, 16 | 7,501,556 | 63.69% |
| 30 Sep, 16 | 4,582,729 | 19.76% |
| 30 Jun, 16 | 3,826,645 | 75.55% |
| 31 Mar, 16 | 2,179,794 | 59.03% |
| 31 Dec, 15 | 1,370,709 | - |
Anavex Life Sciences (AVXL) has 26.77M shares outstanding as of 30 Jun 24, down -15.94% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 32.46% | 2.16% |
| 31 Mar, 24 | 38.80% | 3.94% |
| 31 Dec, 23 | 31.39% | 3.30% |
| 30 Sep, 23 | 30.86% | 2.99% |
| 30 Jun, 23 | 32.15% | 2.71% |
| 31 Mar, 23 | 34.47% | 2.90% |
| 31 Dec, 22 | 34.49% | 3.46% |
| 30 Sep, 22 | 31.55% | 3.08% |
| 30 Jun, 22 | 32.01% | 2.99% |
| 31 Mar, 22 | 32.72% | 3.90% |
| 31 Dec, 21 | 28.96% | 3.96% |
| 30 Sep, 21 | 27.04% | 2.90% |
| 30 Jun, 21 | 30.52% | 4.37% |
| 31 Mar, 21 | 26.42% | 5.64% |
| 31 Dec, 20 | 21.64% | 4.60% |
| 30 Sep, 20 | 21.69% | 5.46% |
| 30 Jun, 20 | 19.94% | 4.99% |
| 31 Mar, 20 | 19.99% | 3.11% |
| 31 Dec, 19 | 25.36% | 3.44% |
| 30 Sep, 19 | 27.15% | 4.85% |
| 30 Jun, 19 | 23.67% | 9.71% |
| 31 Mar, 19 | 15.61% | 7.47% |
| 31 Dec, 18 | 14.46% | 4.61% |
| 30 Sep, 18 | 17.70% | 4.41% |
| 30 Jun, 18 | 20.04% | 3.78% |
| 31 Mar, 18 | 23.01% | 4.33% |
| 31 Dec, 17 | 23.04% | 3.84% |
| 30 Sep, 17 | 24.51% | 3.99% |
| 30 Jun, 17 | 24.78% | 4.79% |
| 31 Mar, 17 | 22.75% | 5.96% |
| 31 Dec, 16 | 19.54% | 13.71% |
| 30 Sep, 16 | 11.94% | 10.39% |
| 30 Jun, 16 | 10.72% | 27.97% |
| 31 Mar, 16 | 6.19% | 38.02% |
| 31 Dec, 15 | 4.03% | - |
As of 30 Jun 24, Anavex Life Sciences is held by 32.46% institutional shareholders, representing a 2.16% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 61 | -18.67% |
| 31 Mar, 24 | 75 | -11.76% |
| 31 Dec, 23 | 85 | 19.72% |
| 30 Sep, 23 | 71 | 10.94% |
| 30 Jun, 23 | 64 | 3.23% |
| 31 Mar, 23 | 62 | -19.48% |
| 31 Dec, 22 | 77 | 10.00% |
| 30 Sep, 22 | 70 | 4.48% |
| 30 Jun, 22 | 67 | -12.99% |
| 31 Mar, 22 | 77 | -9.41% |
| 31 Dec, 21 | 85 | 21.43% |
| 30 Sep, 21 | 70 | -14.63% |
| 30 Jun, 21 | 82 | 13.89% |
| 31 Mar, 21 | 72 | 46.94% |
| 31 Dec, 20 | 49 | 53.13% |
| 30 Sep, 20 | 32 | -11.11% |
| 30 Jun, 20 | 36 | -10.00% |
| 31 Mar, 20 | 40 | 25.00% |
| 31 Dec, 19 | 32 | 6.67% |
| 30 Sep, 19 | 30 | -3.23% |
| 30 Jun, 19 | 31 | 10.71% |
| 31 Mar, 19 | 28 | 47.37% |
| 31 Dec, 18 | 19 | 46.15% |
| 30 Sep, 18 | 13 | -53.57% |
| 30 Jun, 18 | 28 | 33.33% |
| 31 Mar, 18 | 21 | -27.59% |
| 31 Dec, 17 | 29 | 7.41% |
| 30 Sep, 17 | 27 | -22.86% |
| 30 Jun, 17 | 35 | 12.90% |
| 31 Mar, 17 | 31 | -6.06% |
| 31 Dec, 16 | 33 | -2.94% |
| 30 Sep, 16 | 34 | 13.33% |
| 30 Jun, 16 | 30 | 7.14% |
| 31 Mar, 16 | 28 | -6.67% |
| 31 Dec, 15 | 30 | - |
61 institutional shareholders have increased their position in AVXL stock as of 30 Jun 24 compared to 75 in the previous quarter (a -18.67% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | - |
| 31 Mar, 24 | 44 | 15.79% |
| 31 Dec, 23 | 38 | -15.56% |
| 30 Sep, 23 | 45 | -6.25% |
| 30 Jun, 23 | 48 | 20.00% |
| 31 Mar, 23 | 40 | 17.65% |
| 31 Dec, 22 | 34 | 9.68% |
| 30 Sep, 22 | 31 | -18.42% |
| 30 Jun, 22 | 38 | 26.67% |
| 31 Mar, 22 | 30 | 3.45% |
| 31 Dec, 21 | 29 | -6.45% |
| 30 Sep, 21 | 31 | 14.81% |
| 30 Jun, 21 | 27 | 28.57% |
| 31 Mar, 21 | 21 | 5.00% |
| 31 Dec, 20 | 20 | -16.67% |
| 30 Sep, 20 | 24 | 33.33% |
| 30 Jun, 20 | 18 | 28.57% |
| 31 Mar, 20 | 14 | 55.56% |
| 31 Dec, 19 | 9 | -18.18% |
| 30 Sep, 19 | 11 | -21.43% |
| 30 Jun, 19 | 14 | 7.69% |
| 31 Mar, 19 | 13 | 18.18% |
| 31 Dec, 18 | 11 | -35.29% |
| 30 Sep, 18 | 17 | 6.25% |
| 30 Jun, 18 | 16 | 6.67% |
| 31 Mar, 18 | 15 | 15.38% |
| 31 Dec, 17 | 13 | -13.33% |
| 30 Sep, 17 | 15 | 36.36% |
| 30 Jun, 17 | 11 | -38.89% |
| 31 Mar, 17 | 18 | 38.46% |
| 31 Dec, 16 | 13 | 30.00% |
| 30 Sep, 16 | 10 | 25.00% |
| 30 Jun, 16 | 8 | 33.33% |
| 31 Mar, 16 | 6 | - |
| 31 Dec, 15 | - | - |
44 institutional shareholders have reduced their position in AVXL stock as of 30 Jun 24 compared to 44 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 147 | -6.96% | 26,770,048 | -15.94% | 32.46% | 2.16% | 61 | -18.67% | 44 | - |
| 31 Mar, 24 | 158 | -5.39% | 31,845,742 | 23.59% | 38.80% | 3.94% | 75 | -11.76% | 44 | 15.79% |
| 31 Dec, 23 | 167 | 9.87% | 25,766,532 | 3.24% | 31.39% | 3.30% | 85 | 19.72% | 38 | -15.56% |
| 30 Sep, 23 | 152 | -0.65% | 24,959,010 | -0.86% | 30.86% | 2.99% | 71 | 10.94% | 45 | -6.25% |
| 30 Jun, 23 | 153 | 2.00% | 25,175,353 | -6.73% | 32.15% | 2.71% | 64 | 3.23% | 48 | 20.00% |
| 31 Mar, 23 | 150 | -0.66% | 26,990,575 | 0.34% | 34.47% | 2.90% | 62 | -19.48% | 40 | 17.65% |
| 31 Dec, 22 | 151 | -2.58% | 26,897,954 | 10.84% | 34.49% | 3.46% | 77 | 10.00% | 34 | 9.68% |
| 30 Sep, 22 | 155 | -1.27% | 24,268,235 | -2.12% | 31.55% | 3.08% | 70 | 4.48% | 31 | -18.42% |
| 30 Jun, 22 | 157 | 7.53% | 24,792,611 | -0.62% | 32.01% | 2.99% | 67 | -12.99% | 38 | 26.67% |
| 31 Mar, 22 | 146 | -6.41% | 24,947,521 | 13.35% | 32.72% | 3.90% | 77 | -9.41% | 30 | 3.45% |
| 31 Dec, 21 | 156 | 5.41% | 22,009,083 | 7.11% | 28.96% | 3.96% | 85 | 21.43% | 29 | -6.45% |
| 30 Sep, 21 | 148 | 7.25% | 20,548,480 | -4.63% | 27.04% | 2.90% | 70 | -14.63% | 31 | 14.81% |
| 30 Jun, 21 | 138 | 24.32% | 21,545,452 | 18.87% | 30.52% | 4.37% | 82 | 13.89% | 27 | 28.57% |
| 31 Mar, 21 | 111 | 18.09% | 18,125,597 | 30.28% | 26.42% | 5.64% | 72 | 46.94% | 21 | 5.00% |
| 31 Dec, 20 | 94 | 18.99% | 13,912,893 | 10.21% | 21.64% | 4.60% | 49 | 53.13% | 20 | -16.67% |
| 30 Sep, 20 | 79 | 5.33% | 12,624,130 | 7.11% | 21.69% | 5.46% | 32 | -11.11% | 24 | 33.33% |
| 30 Jun, 20 | 75 | 5.63% | 11,785,587 | 1.05% | 19.94% | 4.99% | 36 | -10.00% | 18 | 28.57% |
| 31 Mar, 20 | 71 | 9.23% | 11,663,361 | -16.02% | 19.99% | 3.11% | 40 | 25.00% | 14 | 55.56% |
| 31 Dec, 19 | 65 | 6.56% | 13,888,413 | 4.59% | 25.36% | 3.44% | 32 | 6.67% | 9 | -18.18% |
| 30 Sep, 19 | 61 | -1.61% | 13,278,778 | 13.05% | 27.15% | 4.85% | 30 | -3.23% | 11 | -21.43% |
| 30 Jun, 19 | 62 | 6.90% | 11,746,318 | 59.62% | 23.67% | 9.71% | 31 | 10.71% | 14 | 7.69% |
| 31 Mar, 19 | 58 | 11.54% | 7,358,717 | 9.89% | 15.61% | 7.47% | 28 | 47.37% | 13 | 18.18% |
| 31 Dec, 18 | 52 | 1.96% | 6,696,700 | -18.33% | 14.46% | 4.61% | 19 | 46.15% | 11 | -35.29% |
| 30 Sep, 18 | 51 | -12.07% | 8,199,587 | -9.51% | 17.70% | 4.41% | 13 | -53.57% | 17 | 6.25% |
| 30 Jun, 18 | 58 | - | 9,061,385 | -11.61% | 20.04% | 3.78% | 28 | 33.33% | 16 | 6.67% |
| 31 Mar, 18 | 58 | -7.94% | 10,252,047 | 1.39% | 23.01% | 4.33% | 21 | -27.59% | 15 | 15.38% |
| 31 Dec, 17 | 63 | -3.08% | 10,111,662 | 1.02% | 23.04% | 3.84% | 29 | 7.41% | 13 | -13.33% |
| 30 Sep, 17 | 65 | -4.41% | 10,009,424 | -2.69% | 24.51% | 3.99% | 27 | -22.86% | 15 | 36.36% |
| 30 Jun, 17 | 68 | 3.03% | 10,286,149 | 9.83% | 24.78% | 4.79% | 35 | 12.90% | 11 | -38.89% |
| 31 Mar, 17 | 66 | 1.54% | 9,365,767 | 24.85% | 22.75% | 5.96% | 31 | -6.06% | 18 | 38.46% |
| 31 Dec, 16 | 65 | 8.33% | 7,501,556 | 63.69% | 19.54% | 13.71% | 33 | -2.94% | 13 | 30.00% |
| 30 Sep, 16 | 60 | 20.00% | 4,582,729 | 19.76% | 11.94% | 10.39% | 34 | 13.33% | 10 | 25.00% |
| 30 Jun, 16 | 50 | 11.11% | 3,826,645 | 75.55% | 10.72% | 27.97% | 30 | 7.14% | 8 | 33.33% |
| 31 Mar, 16 | 45 | 32.35% | 2,179,794 | 59.03% | 6.19% | 38.02% | 28 | -6.67% | 6 | - |
| 31 Dec, 15 | 34 | - | 1,370,709 | - | 4.03% | - | 30 | - | - | - |
Anavex Life Sciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Anavex Life Sciences's stock was made by MISSLING CHRISTOPHER U on Apr 01 2024, selling 73,380 shares at $5.11 per share (valued at $374.97K). The last insider buy of AVXL was made by Donhauser Peter D.O. on Jun 17 2024, buying 2,835 shares at $3.64 per share (worth $10.32K).
Anavex Life Sciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 1 | - | - |
| Q1 2024 | 7 | 3 | 233.33% |
| Q2 2023 | 2 | 3 | 66.67% |
| Q1 2023 | 5 | - | - |
| Q2 2022 | 7 | 1 | 700.00% |
| Q3 2021 | 7 | - | - |
| Q2 2021 | 13 | 16 | 81.25% |
| Q1 2021 | 4 | 3 | 133.33% |
| Q4 2020 | 7 | - | - |
| Q1 2020 | 7 | - | - |
| Q2 2019 | 2 | - | - |
| Q4 2018 | 7 | - | - |
| Q2 2018 | 2 | - | - |
| Q1 2018 | 4 | 1 | 400.00% |
| Q4 2017 | 9 | - | - |
| Q3 2017 | 15 | - | - |
| Q2 2017 | 2 | - | - |
| Q1 2017 | - | 1 | - |
| Q3 2016 | 8 | - | - |
| Q2 2016 | 2 | - | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Anavex Life Sciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 1 | - | - |
| Q1 2024 | - | 1 | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | 1 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 1 | 3 | 33.33% |
| Q1 2021 | 2 | 1 | 200.00% |
| Q4 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q2 2019 | - | - | - |
| Q4 2018 | - | - | - |
| Q2 2018 | - | - | - |
| Q1 2018 | 4 | - | - |
| Q4 2017 | 7 | - | - |
| Q3 2017 | 15 | - | - |
| Q2 2017 | - | - | - |
| Q1 2017 | - | - | - |
| Q3 2016 | - | - | - |
| Q2 2016 | - | - | - |
As of Q2 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Anavex Life Sciences's stocks.
Anavex Life Sciences Peer Ownership
| Ticker | Company |
|---|---|
| TGTX | TG Therapeutics, Inc. |
| BTAI | BioXcel Therapeutics, Inc. |
| IOVA | Iovance Biotherapeutics, Inc. |
| EXEL | Exelixis, Inc. |
| RNAZ | TransCode Therapeutics, Inc. |
| VKTX | Viking Therapeutics, Inc. |
| AXSM | Axsome Therapeutics, Inc. |
| BIVI | BioVie Inc. |
| KOD | Kodiak Sciences Inc. |
| EYEN | Eyenovia, Inc. |
| SAVA | Cassava Sciences, Inc. |
| CGTX | Cognition Therapeutics, Inc. |
| NVAX | Novavax, Inc. |
| ANVS | Annovis Bio, Inc. |
| INMB | INmune Bio, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
AVXL Ownership FAQ
Who Owns Anavex Life Sciences?
Anavex Life Sciences is owned by institutional shareholders (32.46%), insiders (3.05%), and public (64.49%). The largest institutional shareholder of Anavex Life Sciences is BLACKROCK INC. (7.75% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.11% of total shares).
Who are the major institutional shareholders of Anavex Life Sciences?
Anavex Life Sciences's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and TWO SIGMA INVESTMENTS, LP. The top five shareholders own together 21.25% of the company's share outstanding.
How many Anavex Life Sciences shareholders are there?
As of Jun 2024, there are 147 institutional shareholders of Anavex Life Sciences.
What percentage of Anavex Life Sciences is owned by BLACKROCK INC?
BLACKROCK INC owns 6.39M shares of Anavex Life Sciences, representing 7.75% of the company's total shares outstanding, valued at $26.97M (as of Jun 2024).
What percentage of Anavex Life Sciences is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 4.55M shares of Anavex Life Sciences (AVXL), compromising 5.52% of the company, valued at $19.19M.
What percentage of Anavex Life Sciences is owned by STATE STREET CORP?
STATE STREET CORP is the third largest holder of Anavex Life Sciences. The company owns 3.74M of the company's shares outstanding (worth $15.78B).